Zota Health Care Limited

NSE ZOTA.NS

Zota Health Care Limited Free Cash Flow Yield on February 06, 2025: -0.91%

Zota Health Care Limited Free Cash Flow Yield is -0.91% on February 06, 2025, a 24.54% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Zota Health Care Limited 52-week high Free Cash Flow Yield is -0.82% on January 17, 2025, which is 9.15% above the current Free Cash Flow Yield.
Zota Health Care Limited 52-week low Free Cash Flow Yield is -1.93% on June 04, 2024, which is -112.46% below the current Free Cash Flow Yield.
Zota Health Care Limited average Free Cash Flow Yield for the last 52 weeks is -1.38%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NSE: ZOTA.NS

Zota Health Care Limited

CEO	Dr. Sujit Paul
IPO Date	May 10, 2017
Location	India
Headquarters	Zota House
Employees	445
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Cosmetics Eyewear Personal Care Pharmaceuticals Specialty Retail

Description

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.

Key trends

Past 5 years